Our resources

Regulatory submissions

Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/​Neck Cancer Patients (2018)
FDA
Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/​Neck Cancer Patients (2018)
READ MORE →
 APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (2019)
FDA
APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (2019)
READ MORE →
 A Study of Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (2021)
FDA
A Study of Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity (2021)
READ MORE →
 A Study of Retatrutide in Participants Who Have Obesity or Overweight (2023)
FDA
A Study of Retatrutide in Participants Who Have Obesity or Overweight (2023)
READ MORE →
 A Study to Test the Effect of Survodutide on Cardiovascular Safety in People With Overweight or Obesity (2023)
FDA
A Study to Test the Effect of Survodutide on Cardiovascular Safety in People With Overweight or Obesity (2023)
READ MORE →
 Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (2019)
FDA
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (2019)
READ MORE →
 CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
FDA
CardiAMP™ Cell Therapy for Heart Failure Trial (2016)
READ MORE →
 Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
FDA
Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery (2023)
READ MORE →
 Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
FDA
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (2019)
READ MORE →
 Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
FDA
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (2019)
READ MORE →
 Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (2021)
FDA
Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (2021)
READ MORE →
 Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (2013)
FDA
Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy (2013)
READ MORE →